Artificial intelligence in healthcare: Intel’s AI tool screens patients for vision loss


In a country like India that has a low doctor-to-patient ratio, artificial intelligence (AI) can enable better access to expert care from anywhere, with telehealth and robotics applied in hospital environments. and ambulatory. Experts say AI will strengthen the role of healthcare in aiding in the detection, diagnosis and treatment of disease, thereby improving quality of life and reducing costs for patients.

“India has a tremendous opportunity to lead human-centric applications and democratize AI for the world by leveraging highly skilled talent, technology, vast data availability and the potential for adoption. of people-wide AI, ”said Prakash Mallya, vice president and general manager of sales, marketing and communications, Intel India.

Intel has focused its efforts on accelerating AI innovation to deliver transformative healthcare solutions and democratize healthcare access and delivery in India. The company’s portfolio of compute, memory, storage and networking technologies powers some of the most exciting applications in health and life sciences.

The cloud-based AI solution Netra.AI is the latest example of the impact and innovation that can be made possible with Intel technology. The solution uses deep learning to identify retinal conditions in a short period of time with the level of precision of human physicians. Netra.AI can accurately identify diabetic retinopathy (DR), dramatically reducing the screening burden for vitreoretinal surgeons. In general, the lack of retinal specialists trained in India, especially in remote rural areas, limits effective screening of asymptomatic patients. This results in late patients with advanced diabetic eye disease.

To address this challenge, the Sankara Eye Foundation collaborated with Leben Care, a Singapore-based deep learning start-up, to develop and implement Netra.AI, a comprehensive software platform of Retinal Risk Assessment as a Service in India. The solution analyzes images from portable, technician-operated fundus cameras for immediate results of the referenced DR rating through a cloud-based web portal. It uses cutting-edge AI algorithms, developed in collaboration with leading retinal experts, with a four-step Deep Convolutional Neural Network (DCNN). This neural network helps detect the DR stage and annotate lesions based on pixel density in fundus images. The solution can be extended to other retinal conditions and glaucoma, reducing the screening burden for healthcare professionals and focusing key resources on patients who require immediate care and intervention.

Mallya says: “The use of AI to improve disease detection and prevention is a critical step for the healthcare industry and a giant leap forward for humanity. Netra.AI, powered by Intel, is a cloud-based AI solution that can scale rapidly to enable faster and more accurate detection of retinal disorders in large populations with limited health resources. The Sankara Eye Foundation and Leben Care have leveraged the power of Intel Xeon Scalable processors and integrated Intel Deep Learning (DL) Boost to accurately detect DR and enable rapid treatment to effectively combat visual impairment and loss of life. preventable blindness in diabetic patients.

Netra.AI is optimized for Intel Xeon Scalable processors with integrated Intel Deep Learning Boost and Intel Advanced Vector Extension 512. Intel architecture provides robust data protection, fast processing of large volumes of data, and service flexibility. The solution provides access to Intel optimized images for TensorFlow, Apache MXNet and PyTorch, in addition to Intel performance libraries, to improve application performance.

The solution is not a substitute for ophthalmologists or retinal surgeons. However, thanks to the easier accessibility of the software and its integration with more portable fundus cameras, which can be used by a single technician, this technology increases access, even for a non-healthcare professional. trained, in screening for DR.

“Technology and AI are democratizing access to care, especially in disease screening. Our team at the Sankara Eye Foundation focused on our vision to eliminate unnecessary blindness in India. The current solution, Netra.AI – for which we played a key role in the design and development with Leben Care – uses robust AI-enabled platforms from Intel. This is an example of how like-minded collaborators can create meaningful and impactful solutions for various challenges facing humanity, ”said Kaushik Murali, President of Medical Administration, Quality and education, Sankara Eye Foundation India.

Netra.AI is a powerful tool for retinal disease screening in large populations with limited infrastructure and resources and an overburdened healthcare system, Intel officials say. The solution offers excellent sensitivity and specificity, 99.7% and 98.5% respectively, for the detection of any RD. It has been shown in India and other countries in Asia and Africa.


Comments are closed.